The largest database of trusted experimental protocols

6 protocols using 1 oleoyl lpa

1

Bone Marrow Stromal Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
The BM stromal cells isolated by collagenase treatment were maintained in α-MEM GlutaMax (Gibco) containing 10% FBS, 10% horse serum (Gibco) and 100 U/ml penicillin/streptomycin (Wako Chemicals, Osaka, Japan) for 7 days. The cells were starved in α-MEM GlutaMax containing 0.1% BSA, 10 μM HA130 (an inhibitor of autotaxin; Calbiochem) and 100 U/ml penicillin/streptomycin for 12 hr to exclude hematopoietic cells. The starved cells were stimulated with 1-oleoyl LPA (Avanti Polar Lipids, Alabaster, AL) at a final concentration of 10 μM by adding an equivalent volume of medium containing 20 μM 1-oleoyl LPA and incubated for 12 hr.
+ Open protocol
+ Expand
2

Lipid Signaling Pathway Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
1-Oleoyl LPA was purchased from Avanti Polar Lipids Inc. Stealth siRNAs against human LPP3, LPA6, Gα13 and RhoA were purchased from Invitrogen. DAPT, thrombin, forskolin, Y27632 and anti-Flag M2 antibody were purchased from Sigma. Alexa-Fluor-594–phalloidin was purchased from Molecular Probes. Recombinant human Dll4 was from R&D Systems.
+ Open protocol
+ Expand
3

Cytosol/Nuclei Fractionation and FoxO1 Halo Pull-down

Check if the same lab product or an alternative is used in the 5 most similar protocols
TAECs were treated with 1-oleoyl-LPA (Avanti Polar Lipids and Sigma-Aldrich), and lysates were collected and subjected to cytosol/nuclei fractionation by a nuclei extraction kit (Millipore). Western blots were used for the detection of targeted proteins with appropriate antibodies as previously described [15 (link)]. Bands on immunoblots were quantified using NIH Image J software. For transfection and Halo pull-down assays, cells were transfected with the plasmids expressing Halo-tagged FoxO1 (Molecular Biology Core, Blood Center of Wisconsin) using Lipofectamine 2000 (Invitrogen) for 24 hours. Transfected cells were treated with LPA (10 μM) for an additional 24 hours before cell lysates were collected and subjected to the Halo pull-down assays according to the manufacturer's instruction (Promega).
+ Open protocol
+ Expand
4

LPA-Induced Signaling Pathway Inhibition

Check if the same lab product or an alternative is used in the 5 most similar protocols
1-Oleoyl LPA (18 : 1 LPA) was purchased from Avanti Polar Lipids (Birmingham, AL, USA). Inhibitor of phosphoinositide 3-kinase (PI3K), LY290042, and inhibitor of mitogen-activated protein kinase (MAPK), PD98059, were from Cell Signaling (Beverly, MA, USA). Rho kinase inhibitor, Y-27632, was from Biomol (Beverly, MA, USA). Hela cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 100 mL/L fetal bovine serum (FBS), streptomycin (100 mg/L), and penicillin (100 KU/L) at 37°C in 50 mL/L CO2 incubator. Cells were serum starved for 12 hours before LPA treatment.
+ Open protocol
+ Expand
5

Optimized Lipid Handling for LPA Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Various chemical forms of LPA were assayed: 1-oleoyl-LPA (18:1), 1-palmitoyl-LPA (16:1), 1-arachidonoyl-LPA (20:4), 1-linoleoyl-LPA (18:2), and 1-oleoyl-lysophosphatidylcholine (18:1 LPC) (Avanti Polar Lipids Inc.). Saturated or mono-unsaturated samples (16:0, 18:1 LPAs, and 18:1 LPC) were completely dissolved in ethanol:water (1:1 v/v) by sonicating for 3–5 min, aliquoted in glass vials layered with N2, and stored under N2 atmosphere at −20°C for several uses (up to 9 months). Unstable and unsaturated LPA samples (18:2 and 20:4; received in CHCl3) were desiccated and then reconstituted in fresh ethanol:water (1:1 v/v) for immediate use in binding assays. Redissolving desiccated LPAs in aqueous BSA solutions for storage purposes was eliminated because it resulted in 95–97% loss of LPA during reconstitution (38 (link)). Stored or reconstituted LPAs in ethanol:water solution show a monodispersed distribution of LPA as measured by dynamic light scattering (DLS). Saturated LPAs are relatively stable under atmosphere, whereas unsaturated ones are highly unstable, extremely hygroscopic, and, therefore, cannot be stored for subsequent use in this assay.
+ Open protocol
+ Expand
6

Preparation and Characterization of Phospholipids

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human recombinant ATX [specific activity: 5.40 or 3.13 U/mg (batch number 0530156–1 or 0584094, respectively)] was purchased from Cayman Chemical (Ann Arbor, MI, USA). 1-oleoyl-LPA (LPA 18:1) and LPC 16:0 were purchased from Sigma-Aldrich (St. Louis, MO, USA) or Avanti Polar Lipids (Alabaster, AL, USA). 1-Oleoyl-cPA (cPA 18:1) was purchased from Avanti Polar Lipids. The purity of cPA obtained from Avanti Polar Lipids, which is frequently highly degraded or contaminated with 1-oleoyl-LPA (up to 98%), is usually confirmed using QqTOF. In this study, we used highly pure cPA, purity was confirmed to be above 97%. Additionally, 2ccPA was also prepared as per previously described4 (link).
3ccPA for TGFα-shedding assay and preparation of the degradation compound, was generously provided by Prof. Susumu Kobayashi (Tokyo University of Science). For other experiments 3ccPA was purchased from Echelon Biosciences (Salt Lake City, UT, USA). N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3-methylaniline, sodium salt, dihydrate (TOOS) was purchased from Dojindo (Kumamoto, Japan). Horseradish peroxidase was purchased from Toyobo Bio (Osaka, Japan). Choline oxidase isolated from Arthrobacter globiformis was kindly provided by Imamura Enzyme Technologies Corp. (Shizuoka, Japan). Acidic methanol (pH 4.0) was prepared as per previously described35 (link).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!